# A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation

> **NCT04308837** · PHASE2 · UNKNOWN · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 29 (estimated)

## Conditions studied

- Gastric Cancer
- Stomach Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **DRUG:** Dexamethasone
- **DRUG:** Diphenhydramine
- **DRUG:** Famotidine
- **DRUG:** Palonosetron
- **RADIATION:** 3D conformal or intensity modulated radiotherapy
- **PROCEDURE:** Surgical resection
- **RADIATION:** Adjuvant Chemotherapy

## Key facts

- **NCT ID:** NCT04308837
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-03
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308837, "A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04308837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*